东宝生物: 关于“东宝转债”转股价格调整的公告

Group 1 - The company has issued convertible bonds amounting to 455 million yuan, with a face value of 100 yuan per bond, totaling 4,550,000 bonds [1] - The initial conversion price for the convertible bonds was set at 6.67 yuan per share, which has been adjusted to 6.65 yuan per share effective from May 31, 2024 [2] - The adjusted conversion price after the latest cash dividend distribution is 6.63 yuan per share, effective from June 17, 2025 [4] Group 2 - The company will adjust the conversion price based on various corporate actions such as stock dividends, capital increases, and cash dividends, following specific formulas [1][2] - The company will disclose any adjustments to the conversion price through official announcements on the Shenzhen Stock Exchange or other designated media [2] - The company has a profit distribution plan for 2024, which does not include stock dividends or capital increases, and will carry forward undistributed profits to future distributions [3]